Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma Academic Article uri icon

Overview

MeSH Major

  • Aminopterin
  • Mesothelioma
  • Palliative Care
  • Pleural Neoplasms

abstract

  • With this particular dose and schedule, pralatrexate as a single agent had no activity in malignant pleural mesothelioma.

publication date

  • April 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.JTO.0000263715.84567.5f

PubMed ID

  • 17409804

Additional Document Info

start page

  • 317

end page

  • 20

volume

  • 2

number

  • 4